Navigation Links
Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend
Date:4/23/2008

rms of individual insurance policies in force in Japan. Our insurance products provide protection to more than 40 million people worldwide. Aflac has been included in Fortune magazine's listing of America's Most Admired Companies for seven years and in Fortune magazine's list of the 100 Best Companies to Work For in America for ten consecutive years. Aflac has also been recognized three times by both Fortune magazine's listing of the Top 50 Employers for Minorities and Working Mother magazine's listing of the 100 Best Companies for Working Mothers. Aflac Incorporated is a Fortune 500 company listed on the New York Stock Exchange under the symbol AFL. To find out more about Aflac, visit aflac.com.

A copy of Aflac's Financial Analysts Briefing (FAB) supplement for the first quarter of 2008 can be found on the "Investors" page at aflac.com.

Aflac Incorporated will webcast its first quarter conference call on the "Investors" page of aflac.com at 9:00 a.m. (EDT) on Thursday, April 24.

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT

(UNAUDITED - IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)

THREE MONTHS ENDED MARCH 31, 2008 2007 % Change

Total revenues $4,267 $3,751 13.8%

Benefits and claims 2,538 2,258 12.4

Total acquisition and operating expenses 1,003 857 17.0

Earnings before income taxes 726 636 14.1

Income taxes 252 220

Net earnings $474 $416 13.9%

Net earnings per share - basic $.99 $.85 16.5%

Net earnings per share - diluted .98 .84 16.7

Shares used to compute earnings per

share (000):

Basic 478,138
'/>"/>

SOURCE Aflac Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Aflac Incorporated To Release First Quarter Results on April 23, 2008
2. Aflac Named Among the 50 Best Companies for Supplier Diversity
3. Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta
4. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
5. Training Magazine Applauds Aflacs Employee Learning Programs
6. Aflac Incorporated Announces Fourth Quarter Results
7. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
8. Aflac to Sponsor Iron Girl
9. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
10. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
11. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008)...HAYWARD, Calif., Aug. 28 /PRNewswire/ -- Guava Tec...greement with Hudson Control Group to,provide drug...for cellular,analyses. This non-exclusive agreemen...ive by Guava Technologies. The initiative is a dir...ll analysis technology to,support higher throughpu...
(Date:8/28/2008)...very from brain injury, not injury itself, associa...Aug. 28 (HealthDay News) -- A group of researchers...brain that is thought to play a key role in Alzhei... known as amyloid beta, was directly linked to bra...r,s disease. When brain cell communication increas...
(Date:8/28/2008)... MessageSolution, Inc., the l...chiving for electronic discovery, litigation suppo...unced that MessageSolution Enterprise Email Archiv...oice Award for Exchange Archiving. Enterprise Ema...pports Microsoft Exchange server versions 5.5 thro...
(Date:8/28/2008)... The Accreditation Council fo... the Education Division of the College of American...th Commendation as a provider of continuing medica... Northfield, IL (PRWEB) August 28, 2008 -- The...ation (ACCME) has awarded the Education Division o...
Breaking Medicine News(10 mins):Health News:San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research 2Health News:San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research 3Health News:Scientists Track Hourly Changes in Alzheimer's Protein 2Health News:MessageSolution Enterprise Email Archive™ Wins MSExchange.org Readers' Choice Award for Exchange Archiving 2Health News:MessageSolution Enterprise Email Archive™ Wins MSExchange.org Readers' Choice Award for Exchange Archiving 3Health News:MessageSolution Enterprise Email Archive™ Wins MSExchange.org Readers' Choice Award for Exchange Archiving 4Health News:MessageSolution Enterprise Email Archive™ Wins MSExchange.org Readers' Choice Award for Exchange Archiving 5Health News:College of American Pathologists' Education Division Receives Top Honor 2Health News:College of American Pathologists' Education Division Receives Top Honor 3
...inister for Health and Family Welfare, announced t...ore on the second phase of the Reproductive and Ch... announced this package at the 49th All India Cong...chi yesterday. He said that the challenge in front...
... be maintained by a low fat diet into old age, acc...ie counting is unnecessary. The study on nearly 50...in the medical journal, the Journal of the America...sion that reducing fat intake to under 20% of the ...
...as revealed that more devastating earthquakes are ...period of 50 years. // They will inflict far great...zaffarabad in Pakistan. Roger Bilham who has been...kistan for the past two months, said that a huge a...
...ult blood test (FOBT) is a simpler way of identify...researchers claim in an article published online i...BT is used to screen individuals who might be havi... substantially the number of false positives in a ...
Other Medicine News:Health News:More Severe Earthquakes May Hit Kashmir In Future 2
(Date:8/27/2008)..., from BLISS-52 trial, expected by mid-2009 - - D...by fall 2009 -, ROCKVILLE, Md., Aug. 27 /PRNewswi...aq: HGSI ) today announced it has completed enrol...f two pivotal Phase 3,randomized clinical trials o...ive systemic lupus erythematosus (SLE). Belimumab ...
(Date:8/26/2008)...ents can drive safely six weeks following surgical...SNewswire/ -- Six weeks following,bunion surgery, ...e able to,get back behind the wheel of a car again...e Journal of Bone and Joint Surgery ( http://www.j...sponse in patients who underwent a,first metatarsa...
(Date:8/26/2008)...ewswire/ -- Omeros Corporation today announced the... trial investigating,OMS103HP in arthroscopic ante...y. OMS103HP is an investigational drug product tha... is designed to improve postoperative,knee functio...patients an,earlier return to work. The article ti...
(Date:8/25/2008)...g. 25 /- Anthera Pharmaceuticals,Inc....oping,anti-inflammatory drugs, today announced the...coronary events with Near-term Cardiovascular,Infl...xamine the impact of,varespladib when administered...Syndrome (ACS) event., The FRANCIS trial is desig...
Breaking Medicine Technology:Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Braking After Bunion Surgery 2Braking After Bunion Surgery 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Shaking may cause brain damage and serious long term effects to infants 1376 1Shaking may cause brain damage and serious long term effects to infants 1376 2American College of Physicians publishes The Fenway Guide to LGBT Health 1374 1American College of Physicians publishes The Fenway Guide to LGBT Health 1374 2IMPACT initiative looks to improve patient participation in clinical trials 1372 1IMPACT initiative looks to improve patient participation in clinical trials 1372 2New genetic research into nicotine addiction shows promise for personalized treatment 421 1New genetic research into nicotine addiction shows promise for personalized treatment 421 2
...esented at ASCO with cediranib - a selective,VEGF ...ents alive,and progression- free at six months(1),...he,investigational agent cediranib (AZD2171) were ...can Society of Clinical Oncology,(ASCO) from a stu...an invasive form of brain tumor with a high unmet ...
...atients With Follicular Lymphoma Reported,Today at.../PRNewswire/ -- GlaxoSmithKline plc,announced toda... a,single one-week course of frontline treatment w... and Iodine I-131 Tositumomab) in,76 patients with...,lymphoma (NHL). This regimen was found to induce ...
Other Medicine Technology:Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 2Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 3Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
A direct qualitative enzyme immunoassay for detection of E.coli Shiga Toxin 1 and 2 in fresh or preserved fecal specimens.
The Directigen™ Meningitis Individual Tests are presumptive latex slide agglutination tests for the direct qualitative detection of antigens to H. influenzae type b, S. pneumoniae, N. meningitid
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease).
The AP250 Auto Projector is a remote-controlled, programmable, random-access, high-resolution, ophthalmic projector.
Medicine Products: